Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mollee

Showing results (1-10 of 145) with videos related to

Pageof 15
Sort By:
The Clinical Biochemist. Reviews|October 21, 2009
Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathiesPeter Mollee
Clinical Chemistry and Laboratory Medicine|January 27, 2016
Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosisPeter Mollee, Giampaolo Merlini
The Medical Journal of Australia|April 3, 2015
Intravenous OxyContin-associated thrombotic microangiopathy treated successfully without plasma exchangeCourtney Tate, Peter Mollee
British Journal of Haematology|July 12, 2017
Monitoring of light chain myeloma - time for a changePeter Mollee, Jill Tate
Leukemia & Lymphoma|October 3, 2018
Pomalidomide - Author ReplyAshleigh P Scott, Peter Mollee
Clinical Chemistry and Laboratory Medicine|December 1, 2018
Response to Letter to the Editor about immunochemical measurement of urine free light chainsJillian R Tate, Peter Mollee
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 31, 2019
Validation of the Boston University staging system in AL amyloidosisRoss Tomlinson, Nicholas Matigian, Peter Mollee
American Journal of Clinical Pathology|July 17, 2009
Borderline high serum free light chain kappa/lambda ratios are seen not only in dialysis patients but also in non-dialysis-dependent renal impairment and inflammatory statesGeorge Marshall, Jill Tate, Peter Mollee
The Clinical Biochemist. Reviews|October 21, 2009
Monoclonal gammopathies--clinical and laboratory issuesJill Tate, Peter Mollee, Roger Johnson
Blood Cancer Journal|January 8, 2021
The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemiaAarya Murali, Donna Cross, Peter Mollee
Pageof 15

Showing results (1-10 of 145) with videos related to

Sort By:
Pageof 15
The Clinical Biochemist. Reviews|October 21, 2009
Current trends in the diagnosis, therapy and monitoring of the monoclonal gammopathiesPeter Mollee
Clinical Chemistry and Laboratory Medicine|January 27, 2016
Free light chain testing for the diagnosis, monitoring and prognostication of AL amyloidosisPeter Mollee, Giampaolo Merlini
The Medical Journal of Australia|April 3, 2015
Intravenous OxyContin-associated thrombotic microangiopathy treated successfully without plasma exchangeCourtney Tate, Peter Mollee
British Journal of Haematology|July 12, 2017
Monitoring of light chain myeloma - time for a changePeter Mollee, Jill Tate
Leukemia & Lymphoma|October 3, 2018
Pomalidomide - Author ReplyAshleigh P Scott, Peter Mollee
Clinical Chemistry and Laboratory Medicine|December 1, 2018
Response to Letter to the Editor about immunochemical measurement of urine free light chainsJillian R Tate, Peter Mollee
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 31, 2019
Validation of the Boston University staging system in AL amyloidosisRoss Tomlinson, Nicholas Matigian, Peter Mollee
American Journal of Clinical Pathology|July 17, 2009
Borderline high serum free light chain kappa/lambda ratios are seen not only in dialysis patients but also in non-dialysis-dependent renal impairment and inflammatory statesGeorge Marshall, Jill Tate, Peter Mollee
The Clinical Biochemist. Reviews|October 21, 2009
Monoclonal gammopathies--clinical and laboratory issuesJill Tate, Peter Mollee, Roger Johnson
Blood Cancer Journal|January 8, 2021
The use of monocyte subset repartitioning by flow cytometry for diagnosis of chronic myelomonocytic leukaemiaAarya Murali, Donna Cross, Peter Mollee
Pageof 15